Chicago, IL
Stem Cell Therapy clinics in Chicago
Chicago supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Northwestern Memorial, Rush University, and University of Chicago, and stem cell practice in the area spans Streeterville, Lincoln Park, and the Gold Coast. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Illinois regulates physician practice through the Department of Financial and Professional Regulation. There is no Illinois-specific stem cell disclosure statute, so federal 21 CFR Part 1271 rules apply. The FDA has issued warning letters to Illinois stem cell operators for unapproved biologics. The 25 Chicago clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Illinois DFPR licensure checks.
Next Health Lincoln Park
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Cryotherapy
MIMIT Health
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Migraine Treatment
- Erectile Dysfunction (ED) Treatment
Bliss MD
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
Midwest Foot and Ankle Clinics
- PRP Therapy
- Shockwave Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Stem Cell Therapy
Bosley - Hair Restoration & Transplant
- PRP Therapy
- Laser Therapy (LLLT)
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
- Stem Cell Therapy
Limitless Health and Wellness
- PRP Therapy
- Arthritis Treatment
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
Lakeshore Hyperbaric Center
- Hyperbaric Oxygen Therapy (HBOT)
- Multiple Sclerosis (MS) Treatment
- Lyme Disease Treatment
- Migraine Treatment
- Stem Cell Therapy
Chicago Arthritis and Regenerative Medicine
- PRP Therapy
- Shockwave Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
RegenerAge
- PRP Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Regulatory context
A note on Illinois's stem cell therapy rules.
Illinois cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Illinois for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Chicago's medical research density also includes legitimate IND-based trials at academic institutions.
-
Illinois Medical Practice Act of 1987, 225 ILCS 60
Establishes physician licensure and discipline through the Illinois Department of Financial and Professional Regulation Medical Disciplinary Board. -
Illinois Pharmacy Practice Act, 225 ILCS 85
Regulates compounding pharmacies aligned with federal 503A and 503B standards relevant to biologic preparation. -
Illinois Consumer Fraud and Deceptive Business Practices Act, 815 ILCS 505
Empowers the Attorney General to pursue deceptive marketing claims against providers making unsupported clinical statements.
The FDA has issued warning letters to Illinois clinics offering stem cell, exosome, and umbilical cord-derived therapies. The Illinois Department of Financial and Professional Regulation has disciplined physicians for unprofessional conduct related to regenerative medicine. The Illinois Attorney General has used the Consumer Fraud and Deceptive Business Practices Act to pursue clinics making unsupported clinical claims, including class-action partnerships with private plaintiffs. Chicago's market draws ongoing federal attention. No statewide injunction parallel to the California SVF case has been issued, but enforcement risk remains material.